220 related articles for article (PubMed ID: 36656211)
1. Correlation NKX2.2 IHC and
Pasricha S; Pahwa S; Pruthi M; Jajodia A; Gupta G; Sharma A; Durga G; Kamboj M; Tiwari A; Panigrahi M; Mehta A
Indian J Pathol Microbiol; 2023; 66(1):58-62. PubMed ID: 36656211
[TBL] [Abstract][Full Text] [Related]
2.
Louati S; Senhaji N; Chbani L; Bennis S
Dis Markers; 2018; 2018():7971019. PubMed ID: 30319719
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of NKX2-2 expression in round cell sarcomas and other tumors with EWSR1 rearrangement: imperfect specificity for Ewing sarcoma.
Hung YP; Fletcher CD; Hornick JL
Mod Pathol; 2016 Apr; 29(4):370-80. PubMed ID: 26847175
[TBL] [Abstract][Full Text] [Related]
4. The combination of CD99 and NKX2.2, a transcriptional target of EWSR1-FLI1, is highly specific for the diagnosis of Ewing sarcoma.
Shibuya R; Matsuyama A; Nakamoto M; Shiba E; Kasai T; Hisaoka M
Virchows Arch; 2014 Nov; 465(5):599-605. PubMed ID: 25031013
[TBL] [Abstract][Full Text] [Related]
5. Review with novel markers facilitates precise categorization of 41 cases of diagnostically challenging, "undifferentiated small round cell tumors". A clinicopathologic, immunophenotypic and molecular analysis.
Machado I; Yoshida A; Morales MGN; Abrahão-Machado LF; Navarro S; Cruz J; Lavernia J; Parafioriti A; Picci P; Llombart-Bosch A
Ann Diagn Pathol; 2018 Jun; 34():1-12. PubMed ID: 29661713
[TBL] [Abstract][Full Text] [Related]
6. Meningeal Ewing Sarcoma/Peripheral PNET: Clinicopathological, Immunohistochemical and FISH study of four cases.
Ke Ch; Duan Q; Yang H; Zhu F; Yan M; Xu SP; Zhou S; Wan F; Shu K; Lei T; Xia LM
Neuropathology; 2017 Feb; 37(1):35-44. PubMed ID: 27500883
[TBL] [Abstract][Full Text] [Related]
7. Does PAX7 and NKX2.2 immunoreactivity in Ewing sarcoma have prognostic significance?
Machado I; Charville GW; Yoshida A; Navarro S; Righi A; Gambarotti M; Scotlandi K; López-Guerrero JA; Llombart-Bosch A
Virchows Arch; 2022 Apr; 480(4):909-917. PubMed ID: 34985580
[TBL] [Abstract][Full Text] [Related]
8. FISH for EWSR1 in Ewing's sarcoma family of tumors: Experience from a tertiary care cancer center.
Murthy SS; Gundimeda SD; Challa S; Manjula V; Fonseca D; Rao VB; Rajappa SJ; N Raju KVV; Rao TS
Indian J Pathol Microbiol; 2021; 64(1):96-101. PubMed ID: 33433416
[TBL] [Abstract][Full Text] [Related]
9. NKX3.1 a useful marker for mesenchymal chondrosarcoma: An immunohistochemical study.
Syed M; Mushtaq S; Loya A; Hassan U
Ann Diagn Pathol; 2021 Feb; 50():151660. PubMed ID: 33302222
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological and molecular spectrum of ewing sarcomas/PNETs, including validation of EWSR1 rearrangement by conventional and array FISH technique in certain cases.
Rekhi B; Vogel U; Basak R; Desai SB; Jambhekar NA
Pathol Oncol Res; 2014 Jul; 20(3):503-16. PubMed ID: 24293381
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical detection of FLI-1 protein expression: a study of 132 round cell tumors with emphasis on CD99-positive mimics of Ewing's sarcoma/primitive neuroectodermal tumor.
Folpe AL; Hill CE; Parham DM; O'Shea PA; Weiss SW
Am J Surg Pathol; 2000 Dec; 24(12):1657-62. PubMed ID: 11117787
[TBL] [Abstract][Full Text] [Related]
12. CD99 and NKX2.2 positive neuroblastoma diagnosed on cytology: A potential diagnostic pitfall and necessity of pathological evaluation of the primary site.
Aparna Devi C; Alashetty S; Champaka G; Dharmalingam P; Kapali A; Kumar N
Diagn Cytopathol; 2023 Jun; 51(6):E189-E194. PubMed ID: 36999306
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of NKX2.2 Immunohistochemistry for Distinguishing Ewing Sarcoma from Other Sinonasal Small Round Blue Cell Tumors.
McCuiston A; Bishop JA
Head Neck Pathol; 2018 Mar; 12(1):89-94. PubMed ID: 28616785
[TBL] [Abstract][Full Text] [Related]
14. Validation of PRKCB Immunohistochemistry as a Biomarker for the Diagnosis of Ewing Sarcoma.
Zota V; Siegal GP; Kelly D; Bridge JA; Berglund A; Bui K; Khalil F; R Reed D; Altiok S; Magliocco A; Bui MM
Fetal Pediatr Pathol; 2023 Apr; 42(2):241-252. PubMed ID: 36062956
[No Abstract] [Full Text] [Related]
15. NKX2.2 is a useful immunohistochemical marker for Ewing sarcoma.
Yoshida A; Sekine S; Tsuta K; Fukayama M; Furuta K; Tsuda H
Am J Surg Pathol; 2012 Jul; 36(7):993-9. PubMed ID: 22446943
[TBL] [Abstract][Full Text] [Related]
16. [Detection of EWSR1 gene rearrangement by fluorescence in situ hybridization in bone and soft tissue tumors: clinical application evaluation and atypical signal analysis].
Li L; Zhang M; Zhang TT; Ding Y
Zhonghua Bing Li Xue Za Zhi; 2024 May; 53(5):458-463. PubMed ID: 38678326
[No Abstract] [Full Text] [Related]
17. NKX2.2 immunohistochemistry in the distinction of Ewing sarcoma from cytomorphologic mimics: Diagnostic utility and pitfalls.
Russell-Goldman E; Hornick JL; Qian X; Jo VY
Cancer Cytopathol; 2018 Nov; 126(11):942-949. PubMed ID: 30376220
[TBL] [Abstract][Full Text] [Related]
18. [Application of the in situ hybridization with EWS dual-color break-apart fluorescence probe and anti-CD99 and anti-FLI-1 antibodies in the diagnosis of Ewing's sarcoma/primitive neuroectodermal tumor].
Liu BY; Yang Y; DU J; Zhang Y; Wang H; Zheng J
Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Aug; 40(4):358-62. PubMed ID: 18677380
[TBL] [Abstract][Full Text] [Related]
19. Report and literature review of four cases of EWSR1::NFATC2 round cell sarcoma.
Liu L; Li L; Ding Y; Kong F; Mo W; Ye H; Shen D
Diagn Pathol; 2024 Jan; 19(1):19. PubMed ID: 38254207
[TBL] [Abstract][Full Text] [Related]
20. The evaluation of CD99 immunoreactivity and EWS/FLI1 translocation by fluorescence in situ hybridization in central PNETs and Ewing's sarcoma family of tumors.
Vural C; Uluoğlu O; Akyürek N; Oğuz A; Karadeniz C
Pathol Oncol Res; 2011 Sep; 17(3):619-25. PubMed ID: 21267687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
